We are live on
!
Find out more
AVA
Atlas Venture Advisors Portfolio holdings
AUM
$122M
1-Year Est. Return
26.28%
This Fund
S&P 500
This Quarter
Est. Return
-6.5%
1 Year Est. Return
-26.28%
3 Year Est. Return
-22.79%
5 Year Est. Return
-46.44%
10 Year Est. Return
–
AUM
$720M
AUM Growth
-$125M
(-15%)
Cap. Flow
-$12.8M
Cap. Flow
% of AUM
-1.78%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
1
Reduced
–
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IAS
Integral Ad Science
IAS
|
+$23 |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCYC
Bicycle Therapeutics
BCYC
|
+$12.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 73.56% |
| 2 | Consumer Discretionary | 25.02% |
| 3 | Healthcare | 1.41% |
Similar funds
RCWM
CCM
SO
MAM
PLC
VAM
TCM
NFGH
Atlas Venture Advisors's Q4 2021 Portfolio in Review
As of Q4 2021, Atlas Venture Advisors held 8 positions worth $720M, down 15% from $845M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Atlas Venture Advisors's Q4 2021 filing shows 1 increased and 1 closed positions. The largest sale was Bicycle Therapeutics, an estimated $12.8M.
By sector, the portfolio is most concentrated in Communication Services at 74% of assets, up from 60% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Atlas Venture Advisors added most to Integral Ad Science in Q4 2021, an estimated $23 increase.
- Atlas Venture Advisors fully exited Bicycle Therapeutics in Q4 2021, selling an estimated $12.8M.
- Atlas Venture Advisors's ten largest holdings make up 100% of its $720M portfolio in Q4 2021.
- Atlas Venture Advisors opened 0 new positions and closed 1 in Q4 2021.
- Atlas Venture Advisors's portfolio value fell 15% quarter-over-quarter to $720M.
Based on Atlas Venture Advisors's 13F filing for Q4 2021, filed 27 Jan 2022.